Clinical trial
Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by…
NCT00318318 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other · Completed
Key facts
| NCT number | NCT00318318 |
|---|---|
| Title | Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array |
| Official title | Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array |
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy, Estrogen Replacement Therapy |
| Intervention type | Drug |
| Interventions | Premarin |
| Enrollment | 20 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Apr 26, 2006 |
| Last update posted | Jul 9, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: